Back to results
US 8,410,056 B2Granted
Pro-oxidant anti-cancer compounds
OwnerStephen John Ralph, Jiri Neuzilinventors
Life of this patent
Estimating the term…
Abstract
This invention relates to anti-cancer compounds and to methods for treating or preventing cancer. In particular, the invention concerns pro-oxidant anti-cancer compounds, such as pro-oxidant forms of vitamin E that selectively interact with complex II of the mitochondrial respiratory chain of cancerous cells, generate reactive oxygen species and induce apoptosis of those cells.
Claims3
A method of testing whether a subject having cancer is likely to respond to therapy comprising the administration of a pro-oxidant compound, said method comprising the steps of:
- (i) introducing the pro-oxidant compound into mitochondria of a cancerous cell sourced from said subject;
- (ii) assaying for the binding of the pro-oxidant compound to a ubiquinone-binding site of complex II of the mitochondria, wherein said assay of step (ii) is selected from the group consisting of assaying for actual binding of the pro-oxidant compound with the ubiquinone-binding site of complex II, or assaying for an effect caused by the binding of the pro-oxidant compound with the ubiquinone-binding site of complex II wherein said effect is not death of the cancerous cell;
- and (iii) assaying for death of the cancerous cell, wherein the binding of the pro-oxidant compound and the death of the cancerous cell by the pro-oxidant compound indicates that the subject is likely to respond to the therapy.
Dependencies are inferred from the claim text.